Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications section now notes that PubMed-derived publications may not be about the study, and the Revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page removed a general government funding/operating status notice, and this change does not affect the study details, eligibility criteria, outcomes, or participation information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check33 days agoChange DetectedThe Study Details page for NCT03879057 remains the same across screenshots, with no updates to design, criteria, or endpoints; any variations are limited to layout or wording.SummaryDifference0.5%

- Check62 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference4%

- Check69 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0 and add a contact/identifier (linshenpku@163.com and 86-10-88196561); remove the old version reference.SummaryDifference0.1%

- Check84 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link/button was removed. This is a minor maintenance change with no impact on core content, pricing, stock, or time slots.SummaryDifference0.2%

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.